China Money Network
Login
Join

Chinese Biotech Startup Harbour BioMed Secures $102.8M In Series C Round

  • July 10, 2020 — 12:50 CST

This Data Is Locked!

This area is available only to Subscribers.

Harbour BioMed, a Shanghai-based biotechnology company focusing on cancer screening, today announced completion of its US$102.8 Million series C round financing to accelerate development of... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: